Trastuzumab Deruxtecan in HER2-Positive Breast Cancer With Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
Nat. Med. 2022 Aug 08;[EPub Ahead of Print], R Bartsch, AS Berghoff, J Furtner, M Marhold, ES Bergen, S Roider-Schur, AM Starzer, H Forstner, B Rottenmanner, K Dieckmann, Z Bago-Horvath, H Haslacher, G Widhalm, A Ilhan-Mutlu, C Minichsdorfer, T Fuereder, T Szekeres, L Oehler, B Gruenberger, CF Singer, A Weltermann, R Puhr, M PreusserFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.